Bioxima Pharmaceuticals Private Limited
About Bioxima Pharmaceuticals Private Limited
Data last updated:
Bioxima Pharmaceuticals Private Limited was a private limited company based in New Delhi, Delhi, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the service-based operations segment of the business services sector. It was incorporated on 27 March 2017.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2017PTC315139. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Roop Singh Chauhan and Mohd Aslam Azad.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office was at A – 195 G/F Bharat Vihar Kakrola, New Delhi, Delhi, India – 110078.
As per the financials filed for FY 2021, the company reported a revenue of ₹85,392, a decline of 32% compared to the previous year. For the same year it recorded a net loss of ₹2.71 Lakh (net margin -317.7%) and EBITDA of -₹2.71 Lakh (EBITDA margin -317.7%). Revenue has declined at a compounded annual rate (CAGR) of 48% over three years.
Company details
Contact details
Bioxima Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressA – 195 G/F Bharat Vihar Kakrola, New Delhi, Delhi, India – 110078
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Bioxima Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Bioxima Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Bioxima Pharmaceuticals Private Limited, buy the company report.
Financials of Bioxima Pharmaceuticals Private Limited
FY 2021 filings availableBioxima Pharmaceuticals Private Limited reported revenue of ₹85,392 (down 32% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 48% over three years, including a 32% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.71 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.71 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -317.7% | ||||
| Net Profit Margin | -317.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bioxima Pharmaceuticals Private Limited, buy the company report.
Board of directors of Bioxima Pharmaceuticals Private Limited
Bioxima Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Roop Singh Chauhan | Director | 27 Mar 2017 | 9 Years 6 Months | As last reported |
| Mohd Aslam Azad | Director | 27 Mar 2017 | 9 Years 6 Months | As last reported |
Peer comparison
Bioxima Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mercure Pharmaceuticals (OPC) Private Limited | ₹85,541 (FY 2025) | 4.0% | Indore, Madhya Pradesh, India | |||
| Savio Remidies Pharmaceuticals Private Limited | ₹85,506 (FY 2024) | -76.0% | Jabalpur, Madhya Pradesh, India | |||
| Bioxima Pharmaceuticals Private Limitedthis company | ₹85,392 (FY 2021) | -₹2.71 Lakh | -317.7% | -32.0% | New Delhi, Delhi, India | |
| Sheer Health Pharmaceuticals Private Limited | ₹84,989 (FY 2023) | -62.0% | Roorkee, Uttarakhand, India | |||
| Mirakare Pharmaceuticals Private Limited | ₹84,739 (FY 2024) | New Delhi, Delhi, India |
To see the full peer comparison of Bioxima Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Bioxima Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bioxima Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Bioxima Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Bioxima Pharmaceuticals Private Limited, buy the company report.
Recent activity
Bioxima Pharmaceuticals Private Limited has 3 board changes on record since 2017: 2 appointments and 1 cessation. The latest: Mohammad Quamre Alam ceased to be Director on 17 Jul 2018.
Frequently asked questions
Bioxima Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Bioxima Pharmaceuticals was a private limited company based in New Delhi, Delhi, India. The company worked in other services, within the business services industry. It was incorporated on 27 March 2017 and is registered under CIN U74999DL2017PTC315139. The company has been struck off by the Registrar of Companies and is no longer operational.
Bioxima Pharmaceuticals had 2 directors:
- Roop Singh Chauhan - Director
- Mohd Aslam Azad - Director
The CIN (Corporate Identification Number) of Bioxima Pharmaceuticals is U74999DL2017PTC315139. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Bioxima Pharmaceuticals is at A – 195 GF Bharat Vihar Kakrola, New Delhi, Delhi, India – 110078.
Bioxima Pharmaceuticals was incorporated on 27 March 2017. It is registered with the Registrar of Companies, Delhi.
The latest financial statements of Bioxima Pharmaceuticals on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from FY 2017 are in the company report.
No. Bioxima Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
Bioxima Pharmaceuticals operated in the business services industry, in the other services segment. It worked in this industry before it was struck off.
The peers of Bioxima Pharmaceuticals by revenue are Mercure Pharmaceuticals (OPC) Private Limited, Savio Remidies Pharmaceuticals Private Limited, Sheer Health Pharmaceuticals Private Limited, Mirakare Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Mohammad Quamre Alam ceased to be Director on 17 Jul 2018. Mohd Aslam Azad was appointed as Director on 27 Mar 2017. Roop Singh Chauhan was appointed as Director on 27 Mar 2017.